Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Circulating DPP3 inhibition restores cardiac function during sepsis in CLP rat models

Sep. 25, 2020

Genhouse Medicine identifies PTPN11 inhibitors

Sep. 25, 2020

Stem cell-derived CC exosomes improve MI recovery in pigs

Sep. 18, 2020

Regeneron initiates phase I study of NPR1 agonist REGN-5381

Sep. 16, 2020

L-606, inhaled liposomal treprostinil-extended release in healthy volunteers

Sep. 10, 2020

Cervello Therapeutics describes new Rho-associated protein kinase inhibitors

Sep. 9, 2020

New thyroid hormone receptor alpha/beta agonists discovered at Nanjing Ruijie Pharma

Sep. 9, 2020

SCAD versus plaques in heart attacks

Sep. 9, 2020

New PCSK9 inhibitors presented by the Wisconsin Alumni Research Foundation

Sep. 8, 2020

QKI-7 targeting restores endothelial cell function and improves vascular complications in diabetes

Sep. 8, 2020

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...